English
Published: 2021-05-27 13:22:48 CEST
Nasdaq Stockholm AB
First North Growth Market - Equities

Listing of Elicera Therapeutics AB, on Nasdaq First North Growth Market (243/21)

Nasdaq Stockholm AB has assessed that Elicera Therapeutics AB, company registration number 556966-4955, fulfills Nasdaq First North Growth Market's listing requirements.

Provided that Elicera Therapeutics AB, applies for admission to trading of its shares on Nasdaq First North Growth Market Sweden, first day of trading is expected to be June 11, 2021.

Shares

 

Short name: ELIC
Maximum number of shares to be listed: 19,782,000
ISIN code: SE0015382080
Round Lot: 1
Order book ID: 226310
Company Registration Number: 556966-4955
Market segment: First North STO/8
Tick Size table: MiFID II tick size table
MIC code: SSME
Trading currency: SEK

 

Equity Rights

 

Short name: ELIC TO1
Maximum number of warrants to be listed: 7,750,000
Terms: 2 TO1 entitles to 1 share at a subscription price of SEK 11.60
Subscription period: November 1, 2022 – November 30, 2022
Last trading day: November 28, 2022
ISIN code: SE0015988233
Round Lot: 1
Order book ID: 226311
Market segment: First North STO/8
Tick Size table: MiFID II tick size table
MIC code: SSME
Trading currency: SEK

   

Classification

 

Code Name
20 Health Care
2010 Health Care


 

This information is distributed at the request of the Certified Adviser, G&W Fondkommission. For further information, please call G&W Fondkommission on +46 8 503 000 50.